Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03SSE
|
||||
Former ID |
DAP000790
|
||||
Drug Name |
Mechlorethamine
|
||||
Synonyms |
Antimit; Carolysine; Caryolysin; Caryolysine; Chlorethazine; Chlormethine; Cloramin; Clormetina; Dichloren; Embechine; Embichin; MBA; Mebichloramine; Mechlorethanamine; Mechloroethamine; Mecloretamina; Mustargen; Mustine; Mutagen; Nitrogranulogen; Thyldiethylamine; Dichlor amine; Me chloroethamine; Mecloretamina [Italian]; Mustine note; Nitrogen mustard; HN2; T 1024; TL 146; Chloramine (the nitrogen mustard); Chlormethine (INN); Chlormethine [INN:BAN]; Chlormethinum [INN-Latin]; Clormetina [INN-Spanish]; ENT-25294; HN-2; IBS-L0033631; Mustargen (TN); N-Lost; N-Methyl lost; Stickstofflost (ebewe); T-1024; Bis(2-chloroethyl)methylamine; Bis(beta-chloroethyl) methylamine; Bis(beta-chloroethyl)methylamine; Di(2-chloroethyl)methylamine; Methylbis(2-chloroethyl)amine; Methylbis(beta-chloroethyl)amine; Methyldi(2-chloroethyl)amine; N-Methyl-lost; N-Methyl-lost [German]; Nitrogen mustard (HN-2); Mitoxine (*Hydrochloride*); N,N-Di(chloroethyl)methylamine; N-Methyl-bis-chloraethylamin; N-Methyl-bis-chloraethylamin [German]; Nitol (*Hydrochloride*); Stickstofflost (*Hydrochloride*); N,N-Bis(2-chloroethyl)methylamine; N-Methyl-bis(2-chloroethyl)amine; N-Methyl-bis(beta-chloroethyl)amine; Beta,beta'-Dichlorodiethyl-N-methylamine; N-Methyl-2,2'-dichlorodiethylamine; N,N-Bis(2-chloroethyl)-N-methylamine; 1,5-Dichloro-3-methyl-3-azapentane hydrochloride; 2,2'-Dichloro-N-me; 2,2'-Dichloro-N-methyldiethylamine; 2,2'-Dichlorodiethyl-methylamine; 2-Chloro-N-(2-chloroethyl)-N-methylethanamine
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Anticancer Agents
|
||||
Company |
Recordati Rare Diseases Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C5H11Cl2N
|
||||
InChI |
InChI=1S/C5H11Cl2N/c1-8(4-2-6)5-3-7/h2-5H2,1H3
|
||||
InChIKey |
HAWPXGHAZFHHAD-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 51-75-2
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9326, 219855, 3135533, 4782132, 7979875, 8149406, 8152524, 10524984, 11335934, 11361173, 11363783, 11366345, 11368907, 11371547, 11374586, 11377069, 11446034, 11462145, 11484232, 11488264, 11490300, 11492739, 11494703, 14772371, 17487142, 26611800, 26679305, 26747396, 26747397, 26747398, 29223144, 37217007, 46505784, 47291165, 47440287, 47662312, 48414146, 48416200, 49857537, 50105642, 51048787, 51091973, 53788825, 57322104, 92124119, 92307214, 99299432, 99301847, 103165035, 104305234
|
||||
ChEBI ID |
ChEBI:28925
|
||||
SuperDrug ATC ID |
L01AA05
|
||||
SuperDrug CAS ID |
cas=000051752
|
||||
Target and Pathway | |||||
Target(s) | DNA | Target Info | Intercalator | [537392] | |
References | |||||
Ref 542232 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7218). | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.